As a tumor suppressor in breast cancer, gastric cancer, pancreatic cancer and renal cell carcinoma, miR-30 prevents proliferation, invasion and metastasis [29–32] by targeting IGF-1R [31]. Here, IGF1R is linked to pancreatic neoplasm.